(Q41875544)

13 October 2017

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient (English)

1 reference

13 October 2017

Torsten H Nielsen

1

1 reference

13 October 2017

Nathalie Johnson

2

1 reference

13 October 2017

Nicolas Garnier

3

1 reference

13 October 2017

Stanley Kwan

4

1 reference

13 October 2017

Lu Yao

5

1 reference

13 October 2017

Eftihia Cocolakis

6

1 reference

13 October 2017

Josée Hébert

7

1 reference

13 October 2017

Robert A Morgan

8

1 reference

13 October 2017

Eric Paquet

9

1 reference

13 October 2017

Kevin P Callahan

10

1 reference

13 October 2017

Craig T Jordan

11

1 reference

13 October 2017

Sarit Assouline

12

1 reference

13 October 2017

Wilson H Miller

13

1 reference

13 October 2017

Koren K Mann

14

1 reference

13 October 2017

12 February 2013

1 reference

Frontiers in Pharmacology

13 October 2017

1 reference

13 October 2017

4

1 reference

13 October 2017

9

1 reference

describes a project that uses

13 October 2017

limma

object named as

limma

2 references

22 June 2022

https://europepmc.org/article/PMC/3570070

based on heuristic

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Darinaparsin: a novel organic arsenical with promising anticancer activity

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

The interleukin-8 pathway in cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

The role of EVI1 in normal and leukemic cells

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3570070

Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23408639

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FPHAR.2013.00009

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

23408639

1 reference